33
total announcements
FERMENTA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 11 Nov 2026
Market Cap
₹1,237 Cr
P/E (TTM)
20.8
EPS (TTM)
₹20.72
52W Low
₹401.00
52W High
₹582.65
Dividend Yield
0.90%
Beta
-0.23
Price / Book
3.0
Debt / Equity
28.3
Revenue (TTM)
₹511 Cr
Gross Margin
60.02%
Operating Margin
10.55%
Fermenta Biotech Limited
Fermenta Biotech Limited has published unaudited financial results for the quarter and half year ended September 30, 2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Investor Presentation for Q2/H1FY27, with a copy of Earnings Presentation enclosed for information.
Fermenta Biotech Limited
Fermenta Biotech Limited has announced its unaudited financial results for H1FY27, with consolidated revenue down 7% YoY to INR 261.9 crore, EBITDA down 34% YoY to INR 45.6 crore, and Profit after Tax down 52% YoY to INR 18.9 crore. Human Nutrition segment grew 2% YoY, while Animal Nutrition segment volumes were down 31% YoY.
Fermenta Biotech Limited
Fermenta Biotech Limited has decided to close its wholly-owned subsidiary, Fermenta Biotech (UK) Limited, due to lack of operations and to reorganize its corporate structure and reduce compliance costs.
Fermenta Biotech Limited
Fermenta Biotech Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, with the company's income at ₹12,058.55 lakhs and expenses at ₹3,162.12 lakhs.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Copy of Newspaper Publication pertaining to Notice for Special window for transfer and dematerialization of physical securities.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting to be held on October 15, 2026.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting(s) to be held on October 14, 2026.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting to be held on October 07, 2026.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting to be held on October 05, 2026.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about a scheduled investor(s) meet on September 29, 2026, in Mumbai, where company officials will discuss press releases and investor presentations available on the company's website.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about a scheduled investor meeting on September 22, 2026, in Mumbai. The meeting will be held in person and will discuss the company's press releases and investor presentations available on its website.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Copy of Newspaper Publication regarding notice to equity shareholders for transfer of shares to IEPF.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about dispatch of letters to shareholders regarding transfer of Equity Shares of the Company to the Investor Education and Protection Fund (IEPF) Account due to unclaimed dividend for 7 consecutive years.
Fermenta Biotech Limited
Fermenta Biotech Limited has entered into an exclusive Licence Agreement with Vellore Institute of Technology (VIT) for Vitamin B12 Fortification Technology.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange regarding Resubmission of the outcome filed on August 11, 2026, in machine readable format, in response to the e-mail received dated September 03, 2026. The company has approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
Fermenta Biotech Limited
Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting(s) to be held on September 03, 2026.